ANDA 75749, held by Intl Medication. Diltiazem Hydrochloride.
As of Nov 16, 2026, ANDA 75749 (Diltiazem Hydrochloride), held by Intl Medication, was first approved by FDA on Nov 21, 2001, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 21, 2001 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Diltiazem Hydrochloride5MG/ML ยท injectable;injection | Diltiazem Hydrochloride | Discontinued |
| Nov 27, 2002 | Supplement 1Manufacturing | Approved | None posted |
| Nov 21, 2001 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters